

 
 INSIGHTi 
 
Hemp Provisions in the House Farm Bill and 
FY2025 Agriculture Appropriations Bill 
June 17, 2024 
Recent action by the House Agriculture Committee on the next farm bill (Farm, Food, and National 
Security Act of 2024; H.R. 8467, as amended) and the House Agriculture Appropriations Subcommittee 
on the FY2025 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies 
Appropriations bill would amend the Domestic Hemp Production Program (§§1639o-s) administered by 
the U.S. Department of Agriculture (USDA) to prohibit the commercial production, sale, and distribution 
of certain intoxicating hemp derivatives and products. Congress is continuing to debate these proposed 
changes as it proceeds to consider these bills. These provisions have both supporters and detractors.  
Existing Hemp-Related Requirements 
The 2018 farm bill (Agriculture Improvement Act of 2018; P.L. 115-334, §12619) legalized hemp by 
establishing a statutory definition for hemp (§7 U.S.C. §1639o) that excludes hemp from the definition of 
marijuana (21 U.S.C. §802(16)) under the Controlled Substances Act (CSA; 21 U.S.C. §§801 et seq.) and 
oversight by the U.S. Drug Enforcement Administration (DEA) (botanically, hemp and marijuana are 
from the same species of plant, Cannabis sativa L). The 2018 farm bill (P.L. 115-334, §§10113-10114) 
established the Domestic Hemp Production Program (§§1639o-s) requiring hemp producers comply with 
USDA regulations promulgated in consultation with the U.S. Attorney General (7 U.S.C. §1639r(a)(1)(B) 
and §1639q(c)(3)). USDA issued its final hemp regulations in January 2021. In enacting the 2018 farm 
bill, Congress preserved the laws and regulations of the Food and Drug Administration (FDA) and the 
Federal Food, Drug, and Cosmetic Act (FFDCA; 21 U.S.C. §§301 et seq.) regarding hemp-derived 
products (7 U.S.C. §1639r(c)). FDA continues to assert that products containing cannabis and cannabis-
derived compounds, including cannabidiol (CBD), tetrahydrocannabinol (THC) derivatives, and other 
cannabinoids remain under its jurisdiction and that it is “unlawful” under the FFDCA “to introduce food 
containing added CBD or THC into interstate commerce, or to market CBD or THC products as, or in, 
dietary supplements, regardless of whether the substances are hemp-derived.”  
Congressional Research Service 
https://crsreports.congress.gov 
IN12381 
CRS INSIGHT 
Prepared for Members and  
 Committees of Congress 
 
  
 
Congressional Research Service 
2 
House Agriculture Committee’s 2024 Farm Bill 
The House Agriculture Committee passed a 2024 farm bill (Farm, Food, and National Security Act of 
2024; H.R. 8467) on May 23, 2024, and would add new and modify existing statutory definitions related 
to hemp cultivation and its products, and make certain changes to how hemp is regulated by USDA.  
H.R. 8467 (§10006) would add a new statutory definition of industrial hemp to mean hemp grown for 
fiber or for the “whole grain, oil, cake, nut, hull, or any other non-cannabinoid compound, derivative, 
mixture, preparation, or manufacture of the seeds of such plant,” among other related changes. H.R. 8467 
would relax certain regulatory requirements for producers of industrial hemp only, including to reduce or 
eliminate testing requirements and background checks, and take steps to eliminate the existing 10-year 
period of ineligibility following the date of conviction for a felony related to a controlled substance. 
Changes related to industrial hemp in H.R. 8467 broadly reflect proposed changes in H.R. 3755/S. 980. 
In addition, H.R. 8467 as amended in an en bloc amendment (#35) would make changes to clarify the 
types of hemp cannabinoid products that would be considered lawful under USDA’s hemp program. (As 
of June 17, 2024, text on congress.gov is not updated.) As passed by committee, the bill would redefine 
the existing statutory definition of hemp (7 U.S.C. §1639o) by replacing language basing the legal limits 
for hemp on its delta-9 tetrahydrocannabinol (delta-9 THC) concentration and instead basing the 
definition on hemp’s “total tetrahydrocannabinol [Total THC] (including tetrahydrocannabinol acid 
(THCA]) concentration.” Other statutory language regarding hemp “derivatives, extracts, cannabinoids, 
isomers, acids, salts, and salts of isomers, whether growing or not” would remain unchanged. The 
amendment specifies that hemp would exclude non-naturally occurring synthetic and intoxicating 
products (i.e., allows only naturally occurring or derived nonintoxicating products). While the amendment 
does not define intoxicating, it would prohibit hemp cannabinoid products with “quantifiable amounts” of 
Total THC (including THCA) or any other cannabinoids that have (or are marketed to have) “similar 
effects on humans or animals” as THC, as determined by USDA. This would not prohibit all hemp 
cannabinoid products, such as CBD, but would require determinations by USDA based on available 
scientific research and quantification methods. This approach recognizes the rapidly evolving landscape 
of hemp derivatives. The amendment further adds a statutory definition of a hemp cannabinoid product 
that would exclude those derived from industrial hemp.  
Changing the basis for determining the legal limits for hemp on its Total THC (including THCA) 
concentration is broadly consistent with regulatory practices established by USDA. (USDA’s 2021 final 
hemp regulations provide a rationale for this determination.) The exclusion of synthetic compounds is 
consistent with an April 2024 determination by DEA regarding the control status of cannabis compound, 
hexahydrocannabinol (HHC) under DEA laws. In that case, DEA determined that HHC “does not occur 
naturally in the Cannabis sativa L. plant and can only be obtained synthetically, and therefore does not 
fall under the definition of hemp.” Some states have adopted or are considering similar restrictions. These 
include prohibition of intoxicating hemp cannabinoid products or regulating such products under a state’s 
medical or recreational marijuana regulations, thus limiting access through a licensed state dispensary. 
House Subcommittee on FY2025 Agriculture 
Appropriations 
The House Agriculture Appropriations Subcommittee’s FY2025 Agriculture Appropriations bill includes 
a provision (§760) that is nearly identical to the en bloc amendment (#35) discussed above. (As of June 
17, 2024, text on congress.gov is not updated.) Accordingly, the bill would clarify that hemp include only 
naturally occurring, non-synthetic, nonintoxicating hemp cannabinoid products and exclude those with 
“quantifiable amounts” of Total THC (including THCA) that have (or are marketed to have) similar
  
Congressional Research Service 
3 
effects as THC, as determined by USDA in consultation with FDA. (Similar to as described above). The 
appropriations provision, however, does not include a definition of industrial hemp, although the bill 
makes allowances for industrial hemp for use in hemp cannabinoid products. This exclusion could create 
confusion since the term is not defined. Appropriations acts usually do not amend the U.S. Code; 
however, this is possible pending resolution of points of order under House rules.  
 
Author Information 
 
Renée Johnson 
   
Specialist in Agricultural Policy 
 
 
 
 
Disclaimer 
This document was prepared by the Congressional Research Service (CRS). CRS serves as nonpartisan shared staff 
to congressional committees and Members of Congress. It operates solely at the behest of and under the direction of 
Congress. Information in a CRS Report should not be relied upon for purposes other than public understanding of 
information that has been provided by CRS to Members of Congress in connection with CRS’s institutional role. 
CRS Reports, as a work of the United States Government, are not subject to copyright protection in the United 
States. Any CRS Report may be reproduced and distributed in its entirety without permission from CRS. However, 
as a CRS Report may include copyrighted images or material from a third party, you may need to obtain the 
permission of the copyright holder if you wish to copy or otherwise use copyrighted material. 
 
IN12381 · VERSION 1 · NEW